Dive Brief:

• The current cost to operate the sanitation department costs between $8 million to $9 million annually. Endless questions were raised by the contract the committee was given, without clear answers, which exasperated the chair of the committee.Republic Services submitted a bid which increases prices to almost double the current rate per household. Republic would also keep all profit generated from recycling.
• Achieving that won't be without challenges, though. Apellis' drug requires a twice-weekly injection that resulted in an injection site reaction in more than a third of patients over the 16-week study. More than one in five patients on pegcetacoplan reported diarrhea, versus none on Soliris.
• Life Sciences organizations are actively looking for ways to balance regulatory and security requirements, as well as existing investments, with the agility, speed of innovation and cost savings of the cloud. However, there are as many different approaches to cloud adoption as there are Life Sciences companies. How can an organization map out the right strategy? Determine the right balance between maintaining control and enabling external partner collaboration or the cost advantages of the cloud and intellectual property protection? And, while cloud adoption is widely cited as an intrinsic element of digital transformation, where does a cloud deployment fit with legacy infrastructure?

Dive Insight:

The current cost to operate the sanitation department costs between $8 million to $9 million annually. Endless questions were raised by the contract the committee was given, without clear answers, which exasperated the chair of the committee.Republic Services submitted a bid which increases prices to almost double the current rate per household. Republic would also keep all profit generated from recycling.

Achieving that won't be without challenges, though. Apellis' drug requires a twice-weekly injection that resulted in an injection site reaction in more than a third of patients over the 16-week study. More than one in five patients on pegcetacoplan reported diarrhea, versus none on Soliris.

Life Sciences organizations are actively looking for ways to balance regulatory and security requirements, as well as existing investments, with the agility, speed of innovation and cost savings of the cloud. However, there are as many different approaches to cloud adoption as there are Life Sciences companies. How can an organization map out the right strategy? Determine the right balance between maintaining control and enabling external partner collaboration or the cost advantages of the cloud and intellectual property protection? And, while cloud adoption is widely cited as an intrinsic element of digital transformation, where does a cloud deployment fit with legacy infrastructure?